Results 11 to 20 of about 354,255 (314)

Nephrolithiasis-induced end stage renal disease

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2010
M Ounissi¹, T Gargueh², M Mahfoudhi¹, K Boubaker¹, H Hedri¹, R Goucha¹, E Abderrahim¹, F Ben Hamida¹, T Ben Abdallah¹, F El Younsi¹, H Ben Maiz³, A Kheder ...
M Ounissi, T Gargueh, M Mahfoudhi, et al
doaj   +1 more source

Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms

open access: yesInternational Journal of Nephrology and Renovascular Disease, 2013
Karthik Ramakrishnan,1 T Christopher Bond,1 Ami Claxton,1 Vipan C Sood,2 Maria Kootsikas,2 Wendy Agnese,2 Scott Sibbel11DaVita Clinical Research, Minneapolis, MN, USA; 2Mitsubishi Tanabe Pharma Corporation, Jersey City, NJ, USAAbstract: One of the most ...
Ramakrishnan K   +6 more
doaj   +1 more source

Low parathyroid hormone level predicts infection-related mortality in incident dialysis patients: a prospective cohort study [PDF]

open access: yesThe Korean Journal of Internal Medicine, 2020
Background/Aims Parathyroid hormone (PTH) is an important factor influencing immunologic dysfunction, but the effect of PTH level on infection-related outcomes remains unclear in incident dialysis.
Yu Ah Hong   +10 more
doaj   +1 more source

Factors Affecting Selection of a Dialysis Modality in Elderly Patients With Chronic Kidney Disease: A Prospective Cohort Study in Korea

open access: yesFrontiers in Medicine, 2022
BackgroundWe investigated factors associated with the selection of a dialysis modality for elderly patients compared to younger patients.MethodsThis study included 2,514 incident dialysis patients from a Korean multicenter prospective cohort ...
Jang-Hee Cho   +25 more
doaj   +1 more source

The benefit of planned dialysis to early survival on hemodialysis versus peritoneal dialysis: a nationwide prospective multicenter study in Korea

open access: yesScientific Reports, 2023
Optimal preparation is recommended for patients with advanced chronic kidney disease to minimize complications during dialysis initiation. This study evaluated the effects of planned dialysis initiation on survival in patients undergoing incident ...
Jeong-Hoon Lim   +12 more
doaj   +1 more source

Frailty in end stage renal disease: Current perspectives

open access: yesNefrologĂ­a, 2022
Frailty is common in end stage renal disease (ESRD) and is a marker of poor outcomes. Its prevalence increases as chronic kidney disease (CKD) progresses. There are different measurement tools available to assess frailty in ESRD.
Shankar Prasad Nagaraju   +2 more
doaj   +3 more sources

How to increase dialysis adequacy; A randomized clinical trial [PDF]

open access: yesJournal of Nephropathology, 2020
Introduction: Studies have shown when hemodialysis treatment is sufficiently effective, complications of uremic syndrome, additional treatment costs and hospitalization length are reduced.
Afsaneh Dashti   +4 more
doaj   +1 more source

The effects of vascular access types on the survival and quality of life and depression in the incident hemodialysis patients

open access: yesRenal Failure, 2020
Background Although arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD), the association between vascular access types and quality of life is not well-known.
Do Hyoung Kim   +8 more
doaj   +1 more source

High rates of tuberculosis in end-stage renal failure: the impact of international migration. [PDF]

open access: yes, 2002
We studied a cohort of patients requiring renal dialysis who had migrated to the United Kingdom from tuberculosis (TB)-endemic countries and found extremely high rates of TB (1,187 cases per 100,000 per year), partly associated with end-stage diabetic ...
Javid, Babak   +11 more
core   +1 more source

Burden of end-stage renal disease of undetermined etiology in Africa

open access: yesRenal Replacement Therapy, 2023
In the last two decades, there have been increasing recognition of excess cases of end-stage renal disease (ESRD) requiring renal replacement therapy without common underlying causes (diabetes, hypertension, glomerulonephritis, or any identifiable cause)
Temesgen Fiseha, Nicholas J. Osborne
doaj   +1 more source

Home - About - Disclaimer - Privacy